Respecting good clinical practices

All UCB-sponsored trials must be performed in line with Good Clinical Practice (GCP) or they will be rejected by the regulators.

GCP is the standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. No trial activity in UCB-sponsored trials will start before approval is obtained from external local ethics committees and health authorities. We always ensure that investigators involved in UCB clinical trials are skilled in the therapeutic area and trained in GCP. Products used in UCB-sponsored clinical trials will be manufactured and controlled according to international and local regulations and laws.